Cencora earnings were $2.5B for the trailing 12 months ending Mar 31, 2026, with 50.8% growth year over year. The latest COR earnings report on Mar 31, 2026 announced Q1 2026 earnings of $1.6B, up 193.3% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, COR reported annual earnings of $1.6B, with 3% growth.
COR past earnings growth
How has COR's earnings growth performed historically?
On COR's earnings call on Invalid Date, Cencora (NYSE: COR) reported Q1 2026 earnings per share (EPS) of $8.44, up 128.11% year over year. Total COR earnings for the quarter were $1.64 billion. In the same quarter last year, Cencora's earnings per share (EPS) was $3.70.
As of the last Cencora earnings report, Cencora is currently profitable. Cencora's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $2.55 billion, a 50.51% increase year over year.
What was COR's earnings growth in the past year?
As of Cencora's earnings date in Invalid Date, Cencora's earnings has grown 50.8% year over year. This is 14.6 percentage points higher than the US Medical Distribution industry earnings growth rate of 36.21%. COR earnings in the past year totalled $2.55 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.